Davos 2022

Global health: Partnering to Stop the World's Biggest Killer

Biopharmaceutical companies can play a greater role in addressing health challenges like cardiovascular disease by partnering with health systems.

Biopharmaceutical companies can play a greater role in addressing health challenges like cardiovascular disease by partnering with health systems. Image: Unsplash/Jesse Orrico

Marie-France Tschudin
President, Innovative Medicines International and Chief Commercial Officer, Novartis
Share:
The Big Picture
Explore and monitor how Health and Healthcare is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Davos 2022

Listen to the article

Discover

How is the World Economic Forum improving the state of healthcare?

Have you read?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Davos 2022Health and HealthcareSDG 03: Good Health and Well-Being
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

What is Davos? Here’s everything you need to know about the World Economic Forum’s Annual Meeting

Gayle Markovitz

December 22, 2022

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum